Domercant Jean Wysler, Puttkammer Nancy, Young Paul, Yuhas Krista, François Kesner, Grand'Pierre Reynold, Lowrance David, Adler Michelle
a Division of Global HIV & TB , Centers for Disease Control and Prevention , Port au Prince , Haiti.
b International Training and Education Center for Health , University of Washington , Seattle , WA , USA.
Glob Health Action. 2017;10(1):1330915. doi: 10.1080/16549716.2017.1330915.
Access to antiretroviral therapy (ART) has expanded in Haiti because of the adoption of Option B+ and the revision of treatment guidelines. Retention in care and treatment varies greatly and few studies have examined retention rates, particularly among women enrolled in Option B+.
To assess attrition among pregnant and non-pregnant patients initiating ART following adoption of Option B+ in Haiti.
Longitudinal data of adult patients initiated on ART from October 2012 through August 2014 at 73 health facilities across Haiti were analyzed using a survival analysis framework to determine levels of attrition. The Kaplan-Meier method and Cox proportional hazards regression were used to examine risk factors associated with attrition.
Among 17,059 patients who initiated ART, 7627 (44.7%) were non-pregnant women, 5899 (34.6%) were men, and 3533 (20.7%) were Option B+ clients. Attrition from the ART program was 36.7% at 12 months (95% CI: 35.9-37.5%). Option B+ patients had the highest level of attrition at 50.4% at 12 months (95% CI: 48.6-52.3%). While early HIV disease stage at ART initiation was protective among non-pregnant women and men, it was a strong risk factor among Option B+ clients. In adjusted analyses, key protective factors were older age (p < 0.0001), living near the health facility (p = 0.04), having another known HIV-positive household member (p < 0.0001), having greater body mass index (BMI) (p < 0.0001), pre-ART counseling (p < 0.0001), and Cotrimoxazole prophylaxis during baseline (p < 0.01). Higher attrition was associated with rapidly starting ART after enrollment (p < 0.0001), anemia (p < 0.0001), and regimen tenofovir+lamivudine+nevirapine (TDF+3TC+NVP) (p < 0.001).
ART attrition in Haiti is high among adults, especially among Option B+ patients. Identifying newly initiated patients most at risk for attrition and providing appropriate interventions could help reduce ART attrition.
由于采用了B+方案并修订了治疗指南,海地接受抗逆转录病毒治疗(ART)的机会有所增加。治疗的留存率差异很大,很少有研究调查留存率,尤其是在参加B+方案的女性中。
评估海地采用B+方案后开始接受ART治疗的孕妇和非孕妇患者的流失情况。
分析了2012年10月至2014年8月期间在海地73家医疗机构开始接受ART治疗的成年患者的纵向数据,使用生存分析框架来确定流失水平。采用Kaplan-Meier方法和Cox比例风险回归分析与流失相关的风险因素。
在17059例开始接受ART治疗的患者中,7627例(44.7%)为非孕妇女性,5899例(34.6%)为男性,3533例(20.7%)为B+方案患者。ART治疗项目在12个月时的流失率为36.7%(95%置信区间:35.9-37.5%)。B+方案患者在12个月时的流失率最高,为50.4%(95%置信区间:48.6-52.3%)。虽然开始接受ART治疗时HIV疾病早期阶段对非孕妇女性和男性有保护作用,但在B+方案患者中却是一个很强的风险因素。在调整分析中,关键的保护因素包括年龄较大(p<0.0001)、居住在医疗机构附近(p=0.04)、有另一位已知的HIV阳性家庭成员(p<0.0001)、体重指数(BMI)较高(p<0.0001)、ART治疗前咨询(p<0.0001)以及基线时服用复方新诺明预防(p<0.01)。较高的流失率与入组后迅速开始ART治疗(p<0.0001)、贫血(p<0.0001)以及使用替诺福韦+拉米夫定+奈韦拉平(TDF+3TC+NVP)方案(p<0.001)有关。
海地成年人中ART治疗的流失率很高,尤其是在B+方案患者中。识别新开始治疗的最易流失风险患者并提供适当干预措施有助于降低ART治疗的流失率。